Medicus Biosciences Email Format
Biotechnology ResearchCalifornia, United States2-10 Employees
Medicus Biosciences is a privately held biotechnology company developing products from HyFlex, a proprietary hydrogel platform technology, for use in human and animal health. The company’s commercial portfolio of veterinary device products include SutureSeal, Membra, Membra Silver, and Membra ABX, for advanced wound care in companion animals, horses, and zoo/exotic species. The Medicus regulated product development program uses the HyFlex technology as a sustained drug delivery vehicle in human ophthalmic products and combination products for osteoarthritis, ophthalmic care and otitis externa in dogs. The Medicus polymer has the ability to deliver a wide range of APIs including corticosteroids, chemotherapeutics, anti-Inflammatory agents, antiseptics, anti-TNF agents, proteins and stem cells. As such, it has potential to fulfill significant unmet clinical needs in veterinary medicine including wound management, otitis, osteoarthritis, joint disease, ophthalmology, gastroenterology, oncology, dentistry and more.